![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
DELIVER Results - Scott D. Solomon, MD (AHAScience) View |
![]() |
Uncovering the Results of the DELIVER Trial (ReachMD) View |
![]() |
A New PARADIGM in Heart Faiure (CSWNews) View |
![]() |
DELIVERing the Details on Dapagliflozin in Heart Failure (Medscape) View |
![]() |
Dr. Scott Solomon: Dapagliflozin Benefits Patients With Heart Failure and Kidney Disease (DocWire) View |
![]() |
HFA 23: The DELIVER Phase III Trial (Radcliffe Cardiology) View |
![]() |
Consistent Benefit of Sacubitril/Valsartan: More from PARADIGM-HF (CSWNews) View |
![]() |
PARADIGM-HF: Combined Neprilysin and Renin-Angiotensin System (RAS) Inhibition (CSWNews) View |
![]() |
HFA 23: DAPA-HF and DELIVER: KCCQ in Patients with Varying Ejection Fraction (Radcliffe Cardiology) View |
![]() |
PARAMOUNT with Dr Scott Solomon - Trials and PIs (theheartorg) View |